NASDAQ
IR-Med Inc. (IRME) has a free cash flow growth of 35.45% as of Friday, May 29, 2026. This represents a 73.62% increase compared to its 12-month average of 20.42%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.